GREAT POINT PARTNERS LLC Quant / Systematic

CIK: 0001281446 · Show all filings

Period: Q1 2019 (← Previous) (Next →)

Filing Date: May 14, 2019

Total Value ($000): $1,010,320 (100.0% shares, 0.0% debt)

Holdings (40)

PTCT PTC THERAPEUTICS INC 6.8%
Value ($000) $68,289 Shares 1,814,260 Est. Cost $27.49 Unrealized +22.1%
ZOGENIX INC 6.5%
Value ($000) $65,987 Shares 1,199,545 Est. Cost $39.55 Unrealized
GLOBAL BLOOD THERAPEUTICS INC 6.2%
Value ($000) $62,457 Shares 1,180,000 Est. Cost $41.05 Unrealized
AUDENTES THERAPEUTICS INC 6.1%
Value ($000) $61,364 Shares 1,572,618 Est. Cost $21.32 Unrealized
ACAD ACADIA PHARMACEUTICALS INC 5.3%
Value ($000) $53,700 Shares 2,000,000 Est. Cost $18.73 Unrealized +24.7%
IOVA IOVANCE BIOTHERAPEUTICS INC 5.2%
Value ($000) $52,945 Shares 5,567,348 Est. Cost $9.91 Unrealized -2.0%
ACCELERON PHARMA INC 5.0%
Value ($000) $50,301 Shares 1,080,113 Est. Cost $10499.23 Unrealized
ASND ASCENDIS PHARMA AS 4.8%
Value ($000) $48,846 Shares 415,000 Est. Cost $117.70 Unrealized
BCRX BIOCRYST PHARMACEUTICALS 4.8%
Value ($000) $48,480 Shares 5,955,762 Est. Cost $5.12 Unrealized +67.3%
INTERCEPT PHARMACEUTICALS INC 4.4%
Value ($000) $44,744 Shares 400,000 Est. Cost Unrealized
UTHR UNITED THERAPEUTICS CORP DEL 4.4%
Value ($000) $44,581 Shares 379,832 Est. Cost $115.96 Unrealized +0.5%
ARRAY BIOPHARMA INC 4.3%
Value ($000) $43,884 Shares 1,800,000 Est. Cost $14.25 Unrealized
KURA KURA ONCOLOGY INC 4.3%
Value ($000) $43,882 Shares 2,645,100 Est. Cost $12.07 Unrealized +27.7%
PBYI PUMA BIOTECHNOLOGY INC 3.5%
Value ($000) $34,911 Shares 900,000 Est. Cost $30.01 Unrealized +1.8%
FIVE PRIME THERAPEUTICS INC 3.2%
Value ($000) $32,139 Shares 2,398,409 Est. Cost $6226.03 Unrealized
GNFTY GENFIT SA 2.9%
Value ($000) $29,528 Shares 1,230,314 Est. Cost $24.00 Unrealized
EPIZYME INC 2.7%
Value ($000) $26,935 Shares 2,173,913 Est. Cost $12.39 Unrealized
ASND ASCENDIS PHARMA AS 2.3%
Value ($000) $23,540 Shares 200,000 Est. Cost $117.70 Unrealized
DERMIRA INC 2.0%
Value ($000) $20,325 Shares 1,500,000 Est. Cost $13.55 Unrealized
MILLENDO THERAPEUTICS INC 1.9%
Value ($000) $19,321 Shares 1,288,093 Est. Cost $7.95 Unrealized
KRYS KRYSTAL BIOTECH INC 1.6%
Value ($000) $16,190 Shares 492,100 Est. Cost $20.94 Unrealized +12.6%
MENLO THERAPEUTICS INC 1.6%
Value ($000) $16,148 Shares 2,057,027 Est. Cost $7.51 Unrealized
CYMABAY THERAPEUTICS INC 1.3%
Value ($000) $13,265 Shares 998,841 Est. Cost $7.87 Unrealized
FIBROGEN INC 1.1%
Value ($000) $10,870 Shares 200,000 Est. Cost Unrealized
CTMX CYTOMX THERAPEUTICS INC 1.0%
Value ($000) $10,310 Shares 959,077 Est. Cost $14.78 Unrealized 0.0%
BIOHAVEN PHARMACTL HLDG CO 1.0%
Value ($000) $10,294 Shares 200,000 Est. Cost Unrealized
FOAMIX PHARMACEUTICALS LTD 1.0%
Value ($000) $10,114 Shares 2,697,133 Est. Cost $7.50 Unrealized
ZAFGEN INC 0.8%
Value ($000) $8,524 Shares 3,110,874 Est. Cost $9.93 Unrealized
DERMIRA INC 0.7%
Value ($000) $7,524 Shares 555,300 Est. Cost $13.55 Unrealized
RVLPQ OSMOTICA PHARMACEUTICALS PLC 0.5%
Value ($000) $5,400 Shares 1,500,000 Est. Cost $8.00 Unrealized -8.0%
ARRAY BIOPHARMA INC 0.5%
Value ($000) $4,876 Shares 200,000 Est. Cost $14.25 Unrealized
SVRA SAVARA INC 0.5%
Value ($000) $4,867 Shares 660,366 Est. Cost $11.29 Unrealized -33.2%
MOMENTA PHARMACEUTICALS INC 0.4%
Value ($000) $4,498 Shares 309,564 Est. Cost $14.53 Unrealized
PROTEOSTASIS THERAPEUTICS INC 0.4%
Value ($000) $4,410 Shares 3,500,000 Est. Cost $2.98 Unrealized
NOVAVAX INC 0.2%
Value ($000) $2,479 Shares 4,500,000 Est. Cost Unrealized
SOLID BIOSCIENCES INC 0.2%
Value ($000) $1,840 Shares 200,000 Est. Cost Unrealized
NOVAVAX INC 0.1%
Value ($000) $1,102 Shares 2,000,000 Est. Cost Unrealized
AKBA AKEBIA THERAPEUTICS INC 0.1%
Value ($000) $1,077 Shares 131,531 Est. Cost $6.86 Unrealized 0.0%
ZYMEWORKS INC 0.0%
Value ($000) $236 Shares 14,610 Est. Cost $16.15 Unrealized
STREAMLINE HEALTH SOLUTIONS 0.0%
Value ($000) $137 Shares 130,137 Est. Cost $6.45 Unrealized